Video Lectures
State-of-the-industry video lectures by leading urology experts
Latest Videos

ALEXANDRIA, VA USA (Press Release) - January 28, 2014 - Studies released today in advance of the 2014 Genitourinary Cancers Symposium reveal survival outcomes in multiple GU cancers and provide insights on the early termination of cancer clinical trials.

This year marks the 10th anniversary of the Symposium, which will be held January 30 – February 1 at the San Francisco Marriott Marquis.

Four key studies were presented in today’s presscast:

 

 

 

“The studies highlighted today present clinicians with a number of thought-provoking and potentially practice-changing implications,” said Charles J. Ryan, MD, moderator of today’s presscast, “Many of which can be integrated into our daily clinical practice and future research efforts.”

Genitourinary cancers include those of the prostate, kidney, bladder, and testis, as well as less common cancers such as those of the penis, ureters, and other urinary organs. In 2014, more than 385,000 people in the United States are expected to be diagnosed with genitourinary cancers, with an estimated 60,500 deaths. The most common genitourinary cancer is prostate cancer, which according to estimates, will be diagnosed in 233,000 men in the United States in 2014 and claim more than 29,400 lives.[i]

The 2014 Genitourinary Cancers Symposium is co-sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO) and the Society of Urologic Oncology (SUO).

About ASCO

The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With nearly 35,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.Cancer.Net.

[i] Siegel, R., Ma, J., Zou, Z. and Jemal, A. (2014), Cancer Statistics, 2014. CA: A Cancer Journal for Clinicians. doi: 10.3322/caac.21208

Contact
Kelly Baldwin
571-483-1365

### 


American Society of Clinical Oncology (ASCO)

 

[ PRESS RELEASE ]

 

 

Calendar
Upcoming urology industry events
August 1-5, 2018 / Sheraton Philadelphia Society Hill Hotel
SUFU Research Foundation Resident Preceptorship 2018
August 3-4, 2018 / Hyatt Regency Washington on Capitol Hill
Best of ASCO 2018 - Washington, DC
August 10-11, 2018 / The Palmer House Hilton, Chicago, IL
Best of ASCO 2018 - Chicago, IL
August 28-31, 2018 / ICS 2018
International Continence Society 2018
Journals
Print publications focusing on urological cancer treatments through original commentary & articles
Everyday Urology Volume 2 Issue 4

Everyday Urology™ - Oncology Insights

From the Editor

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor